ZPD A/S: Financial statements 2013
CVR: 32834825
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ZPD A/S (CVR 32834825) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 43,395,000 and a net result of DKK 16,158,000. Equity in the 2013 report amounted to DKK 105,205,000. The solvency ratio was 89%. The company had 27 employees in the financial year.
- Gross Profit
- DKK 43,395,000
- Profit/Loss
- DKK 16,158,000
- Equity
- DKK 105,205,000
- Total Assets
- DKK 118,144,000
- Employees
- 27
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of September 1, 2013, Frank Marek is registered as økonomidirektør of ZPD A/S.
As of August 21, 2013, is registered as an owner of ZPD A/S with an ownership share of 100%.
As of July 9, 2013, Hiroyasu Nishioka has joined the board of directors of ZPD A/S.
As of July 9, 2013, Keiji Ishiyama has joined the board of directors of ZPD A/S.
ZPD A/S has published its annual report for 2012.
On March 25, 2013, the company changed its name from BIOFAC ESBJERG A/S to ZPD A/S.
About ZPD A/S
ZPD A/S is a Danish company of the type Aktieselskab based in Esbjerg, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named BIOFAC ESBJERG A/S. The management consists of Frank Marek and Hiroyuki Shinya. The board consists of Masakazu Sakurai (chair), Frank Marek and Ken Motegi. The company is owned by Zeria Pharmaceutical Co. Ltd.. The company has 54 employees (2026). In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. Equity in the 2025 report amounted to DKK 217,641,000.